257 related articles for article (PubMed ID: 29626384)
1. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
4. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
[TBL] [Abstract][Full Text] [Related]
5. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
Wald DS; Wald NJ
J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
[TBL] [Abstract][Full Text] [Related]
6. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
7. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
Wald DS; Bestwick JP
Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
[TBL] [Abstract][Full Text] [Related]
8. Progress in the care of familial hypercholesterolaemia: 2016.
Bell DA; Watts GF
Med J Aust; 2016 Sep; 205(5):232-6. PubMed ID: 27581271
[TBL] [Abstract][Full Text] [Related]
9. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
[TBL] [Abstract][Full Text] [Related]
10. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).
Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD
Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia.
Martin AC; Hooper AJ; Norman R; Nguyen LT; Burnett JR; Bell DA; Brett T; Garton-Smith J; Pang J; Nowak KJ; Watts GF
J Paediatr Child Health; 2022 Feb; 58(2):281-287. PubMed ID: 34387892
[TBL] [Abstract][Full Text] [Related]
13. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
[TBL] [Abstract][Full Text] [Related]
15. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.
Ramaswami U; Futema M; Bogsrud MP; Holven KB; Roeters van Lennep J; Wiegman A; Descamps OS; Vrablik M; Freiberger T; Dieplinger H; Greber-Platzer S; Hanauer-Mader G; Bourbon M; Drogari E; Humphries SE
Atherosclerosis; 2020 Jan; 292():178-187. PubMed ID: 31809987
[TBL] [Abstract][Full Text] [Related]
17. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
18. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
[TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
20. Familial Hypercholesterolaemia in the Era of Genetic Testing.
Hughes DP; Viljoen A; Wierzbicki AS
Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
